Ticker brief
HOWL
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
64
authors 14d
27
crowd 14d
+0.27
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-08-20 → 2026-08-26 · now +0.15 (−1 bearish … +1 bullish)
Who spoke27
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @smith_will86715 | C | -3.13 | 14 | +0.21 |
| @AlertsAndNews | C | -1.90 | 8 | +0.35 |
| @BiopharmIQ | B | · | 6 | +0.48 |
| @zohmbastic | C | -1.38 | 5 | +0.34 |
| @StoryTrading | C | +0.28 | 3 | +0.77 |
| @BioStocks | C | -3.02 | 3 | +0.33 |
| @DavidScottAdams | C | -1.92 | 3 | +0.17 |
| @BPharmCatalyst | C | · | 2 | +0.40 |
| @MrStockLockPro1 | C | -0.94 | 2 | +0.20 |
| @mrland_news | C | · | 1 | +0.60 |
| @OTR444 | C | -1.39 | 1 | +0.20 |
| @abc51648039 | C | -1.29 | 1 | +0.20 |
| @ClassicRoy | C | -1.52 | 1 | +0.20 |
| @OpenOutcrier | C | · | 1 | +0.50 |
| @joinlegendsonly | C | -0.81 | 1 | -0.55 |
| @PrismMarketView | C | · | 1 | +0.50 |
| @optionscjp | C | -1.28 | 1 | +0.50 |
| @DekmarTrades | C | -1.24 | 1 | +0.00 |
| @theflynews | C | · | 1 | +0.50 |
| @FluxCharts | C | -3.34 | 1 | +0.35 |
| @fwpharma | B | +0.98 | 1 | +0.20 |
| @VistaPResearch | C | · | 1 | +0.45 |
| @BarchartNews | C | +0.18 | 1 | +0.50 |
| @SuperDuperInvst | C | -0.99 | 1 | +0.00 |
| @Analytica_X | B | +1.03 | 1 | +0.20 |
Recent signals30of 64 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-26 | @IPODave | +0.15 | Hold and trade HOWL between $0.75 and $1.25 into the merger. — Plans to hold and trade the expected $0.75-$1.25 range into the merger. | · | tweet ↗ |
| 2026-08-23 | @DavidScottAdams | +0.10 | Momentum watchlist with chart media but no concrete entry intent. | · | tweet ↗ |
| 2026-08-23 | @AlertsAndNews | +0.55 | Highlights last week's winning names and expresses interest in repeating the performance. | · | tweet ↗ |
| 2026-08-22 | @MrStockLockPro1 | +0.00 | Labels a multi-name watchlist as a recap but provides no visible performance or direction. | · | tweet ↗ |
| 2026-08-21 | @Optimalinvestme | +0.45 | Lists stocks bought and held before the close; output is capped at the first six tickers. | · | tweet ↗ |
| 2026-08-21 | @BiopharmIQ | +0.50 | States that Werewolf and Ambros are joining forces. | · | tweet ↗ |
| 2026-08-21 | @BiopharmIQ | +0.60 | Summarizes the week's largest biotech movers and their associated catalysts. | · | tweet ↗ |
| 2026-08-21 | @Analytica_X | +0.20 | Details HOWL's all-stock Ambros merger, $150M financing, ownership split and planned AMBX rename. | · | tweet ↗ |
| 2026-08-21 | @AlertsAndNews | +0.25 | Promotional weekly recap names prior successful plays without forward trade details. | · | tweet ↗ |
| 2026-08-21 | @SuperDuperInvst | +0.00 | Speculates a sale or asset deal could lift VBIO from $0.12 to $1-$5, citing HOWL as a model. | · | tweet ↗ |
| 2026-08-21 | @DavidScottAdams | +0.20 | Lists five tickers for a power-hour watch without concrete entry intent. | · | tweet ↗ |
| 2026-08-21 | @BiopharmIQ | +0.15 | Notes HOWL's H2 2026 readouts while the merger redirects focus toward a 2028 Phase 3 catalyst. | · | tweet ↗ |
| 2026-08-21 | @BiopharmIQ | +0.50 | HOWL and Ambros agreed to an all-stock merger with a $150M PIPE and planned AMBX ticker. | · | tweet ↗ |
| 2026-08-21 | @BarchartNews | +0.50 | HOWL rose 100% following biotech merger news. | · | tweet ↗ |
| 2026-08-21 | @VistaPResearch | +0.45 | Reports HOWL surging 108.77% to $0.8998; appended biotech tickers are not directly implicated. | · | tweet ↗ |
| 2026-08-21 | @fwpharma | +0.20 | Ambros plans to go public through a reverse merger with Werewolf Therapeutics. | · | tweet ↗ |
| 2026-08-21 | @BiopharmIQ | +0.50 | HOWL and Ambros are merging with $150M funding and a planned AMBX listing. | · | tweet ↗ |
| 2026-08-21 | @BiopharmIQ | +0.60 | Lists opening biotech stock moves and the company events associated with them. | · | tweet ↗ |
| 2026-08-21 | @smith_will86715 | +0.10 | Predicts RIME will surge like HOWL and BTCT. | · | tweet ↗ |
| 2026-08-21 | @FluxCharts | +0.35 | Maps HOWL breakout targets of $0.70-$0.80 and invalidation below $0.35. | · | tweet ↗ |
| 2026-08-21 | @smith_will86715 | +0.10 | Signals an anticipated RIME move similar to HOWL and BTCT. | · | tweet ↗ |
| 2026-08-21 | @StoryTrading | +0.70 | Claims HOWL already delivered a large gain for members. | · | tweet ↗ |
| 2026-08-21 | @smith_will86715 | +0.10 | RIME has $1 on deck on a robotics merger thesis. — Sets a forward $1 target for RIME based on merger and robotics catalysts. | · | tweet ↗ |
| 2026-08-21 | @theflynews | +0.50 | Werewolf and Ambros Therapeutics agreed to combine in an all-stock transaction | · | tweet ↗ |
| 2026-08-21 | @smith_will86715 | +0.10 | Predicts a RIME merger and compares the setup with HOWL. | · | tweet ↗ |
| 2026-08-21 | @smith_will86715 | +0.15 | Promotes RIME as the next HOWL-like setup. | · | tweet ↗ |
| 2026-08-21 | @DekmarTrades | +0.00 | Names two press-release stocks to watch that morning. | · | tweet ↗ |
| 2026-08-21 | @smith_will86715 | +0.55 | Celebrates a sharp positive move in HOWL. | · | tweet ↗ |
| 2026-08-21 | @optionscjp | +0.50 | Premarket roundup reports deal news, crypto gains, a ROST beat and raise, and an OSIS revenue miss. | · | tweet ↗ |
| 2026-08-21 | @smith_will86715 | +0.15 | Promotes RIME at $0.32 as a robotics setup comparable to HOWL. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.